About Kiyatec
Kiyatec is a company based in Pendleton (United States) founded in 2005 by Matt Gevaert. It operates as a HealthTech. Kiyatec has raised $29.49 million across 13 funding rounds from investors including LabCorp, Bruker and HHS. Kiyatec offers products and services including 3D Predict Platform, 3D Predict Tumor-Specific, 3D Predict Glioma, and KIYA-Predict. Kiyatec operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Pendleton, United States
- Founders Matt Gevaert
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kiyatec
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.49 M (USD)
in 13 rounds
-
Latest Funding Round
-
Investors
LabCorp
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kiyatec
Kiyatec offers a comprehensive portfolio of products and services, including 3D Predict Platform, 3D Predict Tumor-Specific, 3D Predict Glioma, and KIYA-Predict. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A platform for tumor-specific cancer treatment prediction.
Tumor-specific analysis for personalized cancer therapy solutions.
Specialized glioma analysis for targeted cancer treatment options.
Predictive tool for oncology treatment planning and decisions.
Unlock access to complete
Funding Insights of Kiyatec
Kiyatec has successfully raised a total of $29.49M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Last Round
-
First Round
First Round
(27 Feb 2009)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series C - Kiyatec | Valuation | MBD Biotech |
|
| Oct, 2024 | Amount | Series C - Kiyatec | Valuation |
investors |
|
| May, 2023 | Amount | Series C - Kiyatec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kiyatec
Kiyatec has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Bruker and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Philanthropic capital is invested to advance brain tumor treatments.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in healthcare and fintech sectors.
|
Founded Year | Domain | Location | |
|
Early-stage ventures in the Southeast are supported by VentureSouth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kiyatec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kiyatec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kiyatec Comparisons
Competitors of Kiyatec
Kiyatec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kiyatec
Frequently Asked Questions about Kiyatec
When was Kiyatec founded?
Kiyatec was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Where is Kiyatec located?
Kiyatec is headquartered in Pendleton, United States. It is registered at Pendleton, Oregon, United States.
Is Kiyatec a funded company?
Kiyatec is a funded company, having raised a total of $29.49M across 13 funding rounds to date.
What does Kiyatec do?
Kiyatec is engaged in developing advanced 3D predictive platforms for cancer care. The company operates within the healthcare and biotechnology sector, specializing in tumor-specific diagnostics and personalized treatment solutions. Platforms such as 3D Predict and KIYA-Predict are designed to assist oncologists, neuro-oncologists, and other healthcare professionals in making informed treatment decisions. Services are extended to patients and caregivers, aiming to improve outcomes in oncology, particularly for complex cases like glioma. The company is headquartered in Greenville, United States, and collaborates with drug development professionals and pharmaceutical researchers to advance cancer therapy solutions.
Who are the top competitors of Kiyatec?
Kiyatec's top competitors include Guardant Health, GRAIL and Foundation Medicine.
What products or services does Kiyatec offer?
Kiyatec offers 3D Predict Platform, 3D Predict Tumor-Specific, 3D Predict Glioma, and KIYA-Predict.
Who are Kiyatec's investors?
Kiyatec has 11 investors. Key investors include LabCorp, Bruker, HHS, SCRA, and The Sontag Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.